Enterprise Value
$2.26 B
-$33.63 M-1.47%
Thu, 28 Nov 2024 00:07:51 GMT
Summary:
Ligand Pharmaceuticals Incorporated enterprise value is currently $2.26 billion, with a fall of -$33.63 million (-1.47%) during the most recent trading day. Over the past year, it has increased by +$1.22 billion (+117.97%). LGND enterprise value is now -65.19% below its all-time high of $6.49 billion.LGND Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -1.5% | -1.4% | -1.4% |
| 1 m1 month | - | +10.4% | +9.6% |
| 3 m3 months | +16.2% | +18.5% | +14.5% |
| 6 m6 months | +52.5% | +51.8% | +44.3% |
| ytdytd | +82.4% | +84.5% | +71.4% |
| 1 y1 year | +118.0% | +120.7% | +103.6% |
| 5 y5 years | -5.8% | +16.8% | +8.6% |
LGND Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $2.29 B | -1.5% | $2.02 B | +11.7% |
| 3 m | 3 months | $2.29 B | -1.5% | $1.77 B | +27.8% |
| 6 m | 6 months | $2.29 B | -1.5% | $1.35 B | +66.9% |
| 1 y | 1 year | $2.29 B | -1.5% | $999 M | +126.2% |
| 3 y | 3 years | $3.03 B | -25.4% | $851 M | +165.6% |
| 5 y | 5 years | $3.88 B | -41.8% | $851 M | +165.6% |
| alltime | all time | $6.49 B | -65.2% | $102 M | +2105.0% |
Ligand Pharmaceuticals Incorporated Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $2.26 B(+82.4%) |
| 2023 | $1.24 B(+5.4%) |
| 2022 | $1.18 B(-59.4%) |
| 2021 | $2.89 B(+44.2%) |
| 2020 | $2.01 B(-13.9%) |
| 2019 | $2.33 B(-30.1%) |
| 2018 | $3.34 B(+7.7%) |
| 2017 | $3.10 B(+33.7%) |
| 2016 | $2.32 B(+2.3%) |
| 2015 | $2.27 B(+110.5%) |
| 2014 | $1.08 B(+0.3%) |
| 2013 | $1.07 B(+134.9%) |
| 2012 | $457.22 M(+79.0%) |
| 2011 | $255.47 M(+49.7%) |
| 2010 | $170.67 M(-37.6%) |
| Date | Value |
|---|---|
| 2009 | $273.40 M(-3.4%) |
| 2008 | $282.92 M(-25.7%) |
| 2007 | $380.72 M(-60.9%) |
| 2006 | $972.98 M(+5.7%) |
| 2005 | $920.81 M(-1.1%) |
| 2004 | $931.09 M(-21.7%) |
| 2003 | $1.19 B(+138.4%) |
| 2002 | $498.59 M(-58.3%) |
| 2001 | $1.20 B(+30.0%) |
| 2000 | $920.46 M(+16.0%) |
| 1999 | $793.50 M(+34.0%) |
| 1998 | $592.03 M(+21.4%) |
| 1997 | $487.63 M(-1.5%) |
| 1996 | $494.81 M(+115.8%) |
| 1995 | $229.30 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated enterprise value?
- What is the all time high enterprise value for Ligand Pharmaceuticals Incorporated?
- What is LGND enterprise value year-to-date change?
- What is Ligand Pharmaceuticals Incorporated enterprise value year-on-year change?
What is Ligand Pharmaceuticals Incorporated enterprise value?
The current enterprise value of LGND is $2.26 B
What is the all time high enterprise value for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high enterprise value is $6.49 B
What is LGND enterprise value year-to-date change?
Ligand Pharmaceuticals Incorporated enterprise value has changed by +$1.02 B (+82.43%) since the beginning of the year
What is Ligand Pharmaceuticals Incorporated enterprise value year-on-year change?
Over the past year, LGND enterprise value has changed by +$1.22 B (+117.97%)